Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
| ||||||
Business Outlook |
| Three Months Ending April 4, 2020 | ||||
|
| GAAP Measure |
| Non-GAAP Adjustments |
| Non-GAAP Measure |
Gross margin |
| 59.50% |
| 0.25% |
| 59.75% |
|
|
|
|
|
|
|
Operating expenses |
| $127.0 |
| $29.5 |
| $97.5 |
|
|
|
|
|
|
|
Effective tax rate |
| 0% |
| 11.5% |
| 11.5% |
|
|
|
|
|
|
|
Diluted earnings (loss) per share - low |
| $(0.03) |
| $0.60 |
| $0.57 |
|
|
|
|
|
|
|
Diluted earnings per share - high |
| $0.07 |
| $0.60 |
| $0.67 |
Silicon Laboratories Inc. | |||
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
| |||
| December 28,
|
| December 29,
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents | $ 227,146 |
| $ 197,043 |
Short-term investments | 498,825 |
| 416,779 |
Accounts receivable, net | 75,639 |
| 73,194 |
Inventories | 73,057 |
| 74,972 |
Prepaid expenses and other current assets | 69,192 |
| 64,650 |
Total current assets | 943,859 |
| 826,638 |
Property and equipment, net | 135,939 |
| 139,049 |
Goodwill | 398,402 |
| 397,344 |
Other intangible assets, net | 134,279 |
| 170,832 |
Other assets, net | 62,374 |
| 90,491 |
Total assets | $1,674,853 |
| $1,624,354 |
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable | $ 38,899 |
| $ 41,171 |
Deferred revenue and returns liability | 19,251 |
| 22,494 |
Other current liabilities | 79,551 |
| 81,180 |
Total current liabilities | 137,701 |
| 144,845 |
Convertible debt | 368,257 |
| 354,771 |
Other non-current liabilities | 53,844 |
| 57,448 |
Total liabilities | 559,802 |
| 557,064 |
Commitments and contingencies |
|
|
|
Stockholders' equity: |
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued | -- |
| -- |
Common stock – $0.0001 par value; 250,000 shares authorized; 43,496 and 43,088 shares issued and outstanding at December 28, 2019 and December 29, 2018, respectively | 4 |
| 4 |
Additional paid-in capital | 133,793 |
| 107,517 |
Retained earnings | 980,608 |
| 961,343 |
Accumulated other comprehensive income (loss) | 646 |
| (1,574) |
Total stockholders' equity | 1,115,051 |
| 1,067,290 |
Total liabilities and stockholders' equity | $1,674,853 |
| $1,624,354 |